Philips Appoints Jan Kimpen as Chief Medical Officer

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) today announced the appointment of Jan Kimpen as the company’s Chief Medical Officer, effective January 1, 2016. This function will play an increasingly important role in supporting the company's strategic focus on the HealthTech market and Dr. Kimpen will add a wealth of related experience to Philips' senior management team. Dr. Kimpen, MD, PhD, professor, joins Philips from the University Medical Center Utrecht (UMC Utrecht) in the Netherlands, where he was Chairman of the Executive Board. He will report to Philips CEO Frans van Houten.

"I am delighted that Jan Kimpen is joining us from UMC Utrecht, which is a highly renowned and innovative hospital in the Netherlands," said Frans van Houten. "The health care industry is undergoing a huge transformation, and Philips' integrated approach to coordinated care across the health continuum is our answer to addressing the industry's dual challenge of delivering better patient outcomes at lower costs. Integrated solutions are at the core of our strategy and in his role as Chief Medical Officer, Jan Kimpen will work closely with our global network of medical thought leaders to ensure that deep clinical insights and a people-focused approach are at the heart of our propositions."

Jan Kimpen (Belgian, 1958) joined UMC Utrecht, one of the largest health care organizations in the Netherlands, in 1997 and became President of the Board in 2009. At UMC Utrecht, Dr. Kimpen strengthened ties with the world-renowned Netherlands Cancer Institute at the Antoni van Leeuwenhoek Hospital (NKI-AVL) and the Netherlands Pediatric Oncology Center. He has been the driving force behind partnerships with Philips and Eindhoven University of Technology, where he is a member of the strategic advisory board Health.

"I very much look forward to joining Philips," said Jan Kimpen. "Given the health care industry’s complexities and interdependencies, it is my firm belief that innovation in health care cannot be achieved in isolation and that collaboration is therefore key to success. My experience in forging partnerships in the public health care sector will provide a strong foundation to expand and deepen Philips' cooperation agreements with the numerous public and private stakeholders in the health care industry."

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 106,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...